Clinical Trials Sponsored by Genome Alberta

Total 3735 results

Second Genome

Terminated

Study of SGM-1019 in Patients With Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic Steatohepatitis

United States
Andrew Penn
Heart and Stroke Foundation of Canada; Genome British Columbia; Bruker Daltonics and other collaborators

Completed

SpecTRA; An Observational Study of the Verification of Protein Biomarkers in Transient Ischemic Attack.

TIA

Canada
Genome & Company

Not yet recruiting

A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Korea, Republic of
CHU de Quebec-Universite Laval
University of British Columbia; McGill University; Canadian Institutes of Health... and other collaborators

Active, not recruiting

PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood (PEGASUS-2)

Aneuploidy | Prenatal Disorder

Canada
University of Alberta
Alberta Health services; Alberta Innovates Health Solutions

Recruiting

Cirrhosis Care Alberta (CCAB): A Pragmatic Type II Hybrid Effectiveness Implementation Trial (CCAB)

Cirrhosis, Liver

Canada
Alberta Health services
Alberta Cancer Foundation

Completed

Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant (HSCT)

Fatigue

Canada
University of Alberta
Alberta Health services

Not yet recruiting

Pediatric Early Rehabilitation in Acute Lymphoblastic Leukemia (PEACE)

Neoplasms | Telemedicine | Pediatric Cancer | Physical Therapy
University of Alberta
Alberta Health services

Recruiting

Clinical Feasibility & Validation of the Virtual Reality GlenxRose Speech-Language Therapies

Speech Disorders | Vocal Cord Dysfunction

Canada
University of Alberta
Alberta Health services

Recruiting

Evaluation of the Effectiveness of Child-oriented Goal-setting in Paediatric Rehabilitation (the ENGAGE Approach)

Neurodevelopmental Disorders

Canada
University of Alberta
Alberta Health services

Completed

RCT Investigating EMDR for Suicidal Ideation

Suicidal Ideation

Canada
University of Alberta
Alberta Health services

Enrolling by invitation

Antihypertensive Deprescribing in Long-term Care (OptimizeBP)

Hypertension | Frailty

Canada
University of Alberta
Alberta Health services

Active, not recruiting

Evaluation of Routinely Measured Patient-reported Outcomes in Hemodialysis Care (EMPATHY)

Chronic Kidney Disease Requiring Chronic Dialysis

Canada
University of Alberta
Alberta Health services

Completed

rTMS With and Without iCBT For the Treatment of Resistant Depression (TRD)

Depressive Disorder, Treatment-Resistant

Canada
University of Alberta
Alberta Health services

Active, not recruiting

Influence of a Gluten Free Food Guide on Diet Quality and Adherence to the GFD in Youth With Celiac Disease

Adherence, Treatment | Gluten Enteropathy | Diet; Deficiency | Celiac Disease in Children

Canada
University of Alberta
Alberta Health services

Terminated

Piloting Conversation Cards for Adolescents

Adolescent Obesity | Health Behavior | Primary Health Care | Life Style | Health Communication

Canada
University of Alberta
Alberta Health services

Completed

18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety

Parkinson Disease | Neuroendocrine Tumors | Neuroblastoma | Congenital Hyperinsulinism | Brain Glioma

Canada
University of Alberta
Alberta Health services

Completed

Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy

Depressive Disorder

Canada
University of Alberta
Alberta Health services

Completed

Feasibility and Effectiveness of Remote Virtual Reality-Based Cardiac Rehabilitation

Myocardial Infarction

Canada
University of Alberta
Alberta Health services

Completed

L-arginine in Treatment as Usual in Schizophrenia

Schizophrenia

Canada
University of Alberta
Alberta Health services

Completed

Evaluation of the Safety and Effectiveness of Stomaphyx for Transoral Incisionless Reduction of the Enlarged Gastric Pouch and Stoma

Morbid Obesity

Canada
University of Alberta
Alberta Health services

Completed

Sustaining Transfers Through Affordable Research Translation (START) (START)

Knowledge Translation | Sustainability of Innovations

Canada
Andrew Penn
Heart and Stroke Foundation of Canada; Genome British Columbia; Vancouver Island... and other collaborators

Completed

SpecTRA; A Study of the Validation of Protein Biomarkers in Transient Ischemic Attack

TIA

Canada
Alberta Health services
University of Alberta

Completed

Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study

Anorexia | Cancer | Taste Disorders | Olfactory Disorders

Canada
Human Genome Sciences Inc.

Completed

A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

United States, Germany, Hungary, Romania
Human Genome Sciences Inc.

Completed

Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)

Lupus Erythematosus, Systemic

United States, Canada
Human Genome Sciences Inc.

Completed

Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy

HIV Infections

United States
Human Genome Sciences Inc.

Completed

Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

United States
University of Alberta
Alberta Health services

Not yet recruiting

Optimizing the Management of Staphylococcus Aureus Bacteremia (OPTIMUS-SAB)

Staph Aureus Bacteremia
University of Alberta
Alberta Health services

Recruiting

Evaluation of Effectiveness of Child-oriented Goal-setting in Paediatric Rehabilitation (the ENGAGE Approach)

Cerebral Palsy | Neurodevelopmental Disorders | Autism Spectrum Disorder

Canada
University of Alberta
Alberta Health services

Active, not recruiting

A Feasibility Study of a Virtual Rehabilitation and Physical Activity Program for People With Advanced Cancer (ACTIVE-North)

Advanced Cancer

Canada
University of Alberta
Alberta Cancer Foundation

Completed

Swallowing Therapy With the Assistance of a Mobile Health Device in Head and Neck Cancer Patients: a Pan-Alberta Study

Head and Neck Cancer | Dysphagia

Canada
University of Alberta
Alberta Health services

Active, not recruiting

NESBID: Neuro-Stimulation of the Brain in Depression (NESBID)

Depressive Disorder, Major | Depressive Disorder, Treatment-Resistant | Electric Stimulation Therapy | Transcranial Direct Current Stimulation

Canada
University of Alberta
Alberta Health services

Completed

2B or Not 2B? Shoulder Function After Level 2B Neck Dissection: A Randomized Controlled Study (2BN2B)

Head and Neck Squamous Cell Carcinoma

Canada
University of Alberta
Alberta Health services

Completed

Peer Support Experience for Patients Discharged From Acute Psychiatric Care

Depression | Schizophrenia | Bipolar Disorder

Canada
University of Alberta
Alberta Health services

Terminated

Group CBT and Exercise in Management of Depression

Major Depressive Disorder

Canada
University of Alberta
Alberta Health services

Completed

Gastric Procedures for Obesity

Morbid Obesity
University of Alberta
Alberta Health services

Completed

Outcomes of the Adjustable Gastric Band in a Publicly Funded Obesity Program

Morbid Obesity

Canada
University of Alberta
Alberta Health services

Completed

Supportive Text Messages to Reduce Mood Symptoms and Problem Drinking- Randomised Controlled Pilot Trials

Depression | Alcoholism

Canada
University of Alberta
Alberta Diabetes Institute

Completed

Exercise Intensity, Glycemic Control and Abdominal Fat in People With Type 2 Diabetes: A Pilot Study

Type 2 Diabetes Mellitus

Canada
Government of Alberta
University of Alberta

Unknown

Rhodiola Rosea for Mental and Physical Fatigue

Fatigue

Canada
Human Genome Sciences Inc.

Completed

A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1

Hepatitis C, Chronic

Canada, Australia, Israel, Germany, Czech Republic, France, Poland, Romania
Human Genome Sciences Inc.

Completed

Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States, Canada, Australia, India
Human Genome Sciences Inc.

Terminated

A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01

Rheumatoid Arthritis

United States, Poland
Human Genome Sciences Inc.

Completed

Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

United States
Human Genome Sciences Inc.

Completed

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Lymphoma, Non-Hodgkin

United States
Human Genome Sciences Inc.

Completed

A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3

Chronic Hepatitis C

Canada
Human Genome Sciences Inc.

Withdrawn

Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis

Ulcerative Colitis
Human Genome Sciences Inc.

Completed

A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States
Human Genome Sciences Inc.

Completed

A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)

Arthritis, Rheumatoid

United States
Human Genome Sciences Inc.

Completed

A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C

Hepatitis C

United States

Clinical Trials Sponsored by Genome Alberta

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations